Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Coordinate regulation of metabolic enzymes and transporters by nuclear transcription factors in human liver disease.

Congiu M, Mashford ML, Slavin JL, Desmond PV.

J Gastroenterol Hepatol. 2009 Jun;24(6):1038-44. doi: 10.1111/j.1440-1746.2009.05800.x.

PMID:
19638083
2.

UDP glucuronosyltransferase mRNA levels in human liver disease.

Congiu M, Mashford ML, Slavin JL, Desmond PV.

Drug Metab Dispos. 2002 Feb;30(2):129-34.

PMID:
11792680
3.

Impact of a toxicology service on a metropolitan teaching hospital.

Lee V, Kerr JF, Braitberg G, Louis WJ, O'Callaghan CJ, Frauman AG, Mashford ML.

Emerg Med (Fremantle). 2001 Mar;13(1):37-42.

PMID:
11476409
4.

Pharmacotherapeutics: what a difference five decades makes!

Day RO, Mashford ML.

Med J Aust. 2001 Jan 1;174(1):48-51.

PMID:
11219795
5.

Bilirubin and bile acids may modulate their own metabolism via regulating uridine diphosphate-glucuronosyltransferase expression in the rat.

Li YQ, Prentice DA, Howard ML, Mashford ML, Desmond PV.

J Gastroenterol Hepatol. 2000 Aug;15(8):865-70.

PMID:
11022826
6.

Alcohol up-regulates UDP-glucuronosyltransferase mRNA expression in rat liver and in primary rat hepatocyte culture.

Li YQ, Prentice DA, Howard ML, Mashford ML, Wilson JS, Desmond PV.

Life Sci. 2000;66(7):575-84.

PMID:
10794513
7.

The effect of hormones on the expression of five isoforms of UDP-glucuronosyltransferase in primary cultures of rat hepatocytes.

Li YQ, Prentice DA, Howard ML, Mashford ML, Desmond PV.

Pharm Res. 1999 Feb;16(2):191-7.

PMID:
10100302
8.

Regulation of uridine diphosphate glucuronosyltransferase during the acute-phase response.

Strasser SI, Mashford ML, Desmond PV.

J Gastroenterol Hepatol. 1998 Jan;13(1):88-94.

PMID:
9737578
9.

Sex hormones differentially regulate isoforms of UDP-glucuronosyltransferase.

Strasser SI, Smid SA, Mashford ML, Desmond PV.

Pharm Res. 1997 Sep;14(9):1115-21.

PMID:
9327435
10.

UDP-glucuronosyltransferase in the regenerating rat liver.

Pellizzer AM, Smid SA, Strasser SI, Lee CS, Mashford ML, Desmond PV.

J Gastroenterol Hepatol. 1996 Dec;11(12):1130-6.

PMID:
9034932
11.

UDP glucuronosyltransferase in the cirrhotic rat liver.

Debinski HS, Mackenzie PI, Lee CS, Mashford ML, Danks JA, Tephly TR, Green M, Desmond PV.

J Gastroenterol Hepatol. 1996 Apr;11(4):373-9.

PMID:
8713705
12.

Assessment of general practitioners' management of hyperlipidaemia. A study using personal visits and a scenario-based questionnaire.

Lewis C, Howard D, Moulds RF, Mashford ML.

Aust Fam Physician. 1994 Oct;23(10):1934, 1937-41.

PMID:
7818393
13.

Release of latent glucuronosyltransferase activity contributes to the sparing of glucuronidation in experimental liver injuries.

Desmond PV, Smyth FE, Mashford ML.

J Gastroenterol Hepatol. 1994 Jul-Aug;9(4):350-4.

PMID:
7948817
14.
15.

Improving the quality of antibiotic prescription patterns in general practice. The role of educational intervention.

De Santis G, Harvey KJ, Howard D, Mashford ML, Moulds RF.

Med J Aust. 1994 Apr 18;160(8):502-5.

PMID:
8170427
16.

The effect of a nutritional model of chronic liver injury on the hepatic glucuronidation of morphine in rats.

Callaghan R, Desmond PV, Mashford ML.

J Pharm Pharmacol. 1993 Nov;45(11):998-9.

PMID:
7908047
17.

Implementing clinical guidelines. It works in Australia.

Hemming M, Mashford ML.

BMJ. 1993 Sep 11;307(6905):678. No abstract available.

18.

Hepatic enzyme activity is the major factor determining elimination rate of high-clearance drugs in cirrhosis.

Callaghan R, Desmond PV, Paull P, Mashford ML.

Hepatology. 1993 Jul;18(1):54-60.

PMID:
8325621
19.

Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures.

Schapel GJ, Beran RG, Vajda FJ, Berkovic SF, Mashford ML, Dunagan FM, Yuen WC, Davies G.

J Neurol Neurosurg Psychiatry. 1993 May;56(5):448-53.

20.

Rational therapeutics: the way ahead.

Moulds RF, Mashford ML.

Med J Aust. 1992 Jun 15;156(12):823-4. No abstract available.

PMID:
1603002
21.

Arterial lignocaine concentrations following cervical plexus blockade for carotid endarterectomy.

Dawson AR, Dysart RH, Amerena JV, Braniff V, Davies MJ, Cronin KD, Mashford ML.

Anaesth Intensive Care. 1991 May;19(2):197-200.

PMID:
2069239
22.

Covert self poisoning with brodifacoum, a 'superwarfarin'.

Wallace S, Worsnop C, Paull P, Mashford ML.

Aust N Z J Med. 1990 Oct;20(5):713-5.

PMID:
2285388
23.

The effect of an antacid and food on the absorption of cimetidine and ranitidine.

Desmond PV, Harman PJ, Gannoulis N, Kamm M, Mashford ML.

J Pharm Pharmacol. 1990 May;42(5):352-4.

PMID:
1976784
24.

Adverse effects of anticoagulants.

Amerena J, Mashford ML, Wallace S.

Adverse Drug React Acute Poisoning Rev. 1990 Spring;9(1):1-36. Review. No abstract available.

PMID:
2190452
25.

A decade of antibiotic use in a teaching hospital.

Raymond PM, Robertson MB, Mashford ML.

Med J Aust. 1989 Jun 5;150(11):619-23, 626.

PMID:
2725376
26.

Hepatic extraction of morphine is impaired in cirrhosis.

Crotty B, Watson KJ, Desmond PV, Mashford ML, Wood LJ, Colman J, Dudley FJ.

Eur J Clin Pharmacol. 1989;36(5):501-6.

PMID:
2753069
27.

Changing antibiotic prescribing by educational marketing.

Landgren FT, Harvey KJ, Mashford ML, Moulds RF, Guthrie B, Hemming M.

Med J Aust. 1988 Dec 5-19;149(11-12):595-9.

PMID:
3200183
28.

Nuclear war and anxiety.

Mashford ML.

Aust Fam Physician. 1988 Sep;17(9):733. No abstract available.

PMID:
3240185
29.

Modified trimethoprim-sulphamethoxazole doses in Pneumocystis carinii pneumonia.

McLean I, Lucas CR, Mashford ML, Harman PJ.

Lancet. 1987 Oct 10;2(8563):857-8. No abstract available.

PMID:
2889058
30.

Adverse drug reactions. Important issues.

Mashford ML.

Aust Fam Physician. 1987 Jul;16(7):912-3. No abstract available.

PMID:
3662955
31.

Studies on the mechanisms of action of activated charcoal on theophylline pharmacokinetics.

Mckinnon RS, Desmond PV, Harman PJ, Kamm M, Ghabrial H, Martin CJ, Mashford ML.

J Pharm Pharmacol. 1987 Jul;39(7):522-5.

PMID:
2886620
32.

Felodipine compared to prazosin as additional therapy to a beta-blocking drug.

Chalmers J, Wing L, West M, Bune A, Johnston C, Jackson B, McGrath B, Mashford ML, Heath W, Westwood B, et al.

J Cardiovasc Pharmacol. 1987;10 Suppl 10:S82-4.

PMID:
2455150
33.

The unsuitability of minoxidil for the treatment of moderate hypertension.

Westwood BE, Wilson M, Heath WC, Hammond JJ, Mashford ML.

Med J Aust. 1986 Aug 4-18;145(3-4):151-2.

PMID:
3526102
34.

Overdose--a problem that is still with us.

Buchanan MC, Harman PJ, Mashford ML.

Med J Aust. 1986 Apr 28;144(9):450-1. No abstract available.

PMID:
3702789
35.

Liquid chromatographic assay for debrisoquine and 4-hydroxydebrisoquine in urine.

Westwood BE, Harman PJ, Mashford ML.

J Chromatogr. 1986 Jan 10;374(1):200-3. No abstract available.

PMID:
3949930
36.

The effects of age and chronic liver disease on the elimination of temazepam.

Ghabrial H, Desmond PV, Watson KJ, Gijsbers AJ, Harman PJ, Breen KJ, Mashford ML.

Eur J Clin Pharmacol. 1986;30(1):93-7.

PMID:
2872062
37.

Appetite suppressant drugs.

Mashford ML.

Med J Aust. 1985 Dec 9-23;143(12-13):605-7. No abstract available.

PMID:
3831751
38.

Mianserin. An example of balancing benefits and risks in therapy.

Mashford ML.

Med J Aust. 1984 Sep 1;141(5):308-10. No abstract available.

PMID:
6433157
39.

Disposition of intravenous glycofurol: effect of hepatic cirrhosis.

Bury RW, Breen KJ, Desmond PV, Raymond K, Mashford ML.

Clin Pharmacol Ther. 1984 Jul;36(1):82-4.

PMID:
6734054
40.

Anorectic drugs. A cause of pulmonary hypertension?

Mashford ML.

Med J Aust. 1984 May 12;140(10):597. No abstract available.

PMID:
6717334
41.

Decreased oral warfarin clearance after ranitidine and cimetidine.

Desmond PV, Mashford ML, Harman PJ, Morphett BJ, Breen KJ, Wang YM.

Clin Pharmacol Ther. 1984 Mar;35(3):338-41.

PMID:
6321081
42.

Use of single doses and rapid sampling to detect interactions with cimetidine.

Ghabrial H, Harman PJ, Desmond PV, Mashford ML, Breen KJ.

Eur J Clin Pharmacol. 1984;27(5):603-6.

PMID:
6519166
43.

A [14C]phenacetin breath test to measure hepatic function in man.

Breen KJ, Bury RW, Calder IV, Desmond PV, Peters M, Mashford ML.

Hepatology. 1984 Jan-Feb;4(1):47-52.

PMID:
6420304
44.
45.

Elimination of amphotericin B in impaired renal function.

Morgan DJ, Ching MS, Raymond K, Bury RW, Mashford ML, Kong B, Sabto J, Gurr FW, Somogyi AA.

Clin Pharmacol Ther. 1983 Aug;34(2):248-53.

PMID:
6872420
46.

Ranitidine does not affect chlormethiazole or indocyanine green disposition.

Mashford ML, Harman PJ, Morphett BJ, Breen KJ, Desmond PV.

Clin Pharmacol Ther. 1983 Aug;34(2):231-3.

PMID:
6307580
47.

Absorption of orally administered amphotericin B lozenges.

Ching MS, Raymond K, Bury RW, Mashford ML, Morgan DJ.

Br J Clin Pharmacol. 1983 Jul;16(1):106-8.

48.

Acute phenylbutazone poisoning in a child.

Bury RW, Mashford ML, Glaun BP, Saaroni G.

Med J Aust. 1983 May 14;1(10):478-9.

PMID:
6843432
49.

The effect of ethanol administration on the disposition and elimination of chlormethiazole.

Bury RW, Desmond PV, Mashford ML, Westwood B, Shaw G, Breen KJ.

Eur J Clin Pharmacol. 1983;24(3):383-5.

PMID:
6861852
50.

Common drug interactions.

Mashford ML.

Aust Fam Physician. 1982 Dec;11(12):925-6. No abstract available.

PMID:
7159281

Supplemental Content

Loading ...
Support Center